Multifaceted roles of melatonin in oncology: an insight into its therapeutic potential in cancer management
Inflammopharmacology · 2025-05 · 33 (5) · 2477-2492
DOI: 10.1007/s10787-025-01751-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Inflammopharmacology, online erschienen am 22.04.2025. Verfasst von Hossein Maghsoudi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Urmia University of Medical Sciences, Urmia, 57147-83734, Iran. Hauptthemen laut MEDLINE: Melatonin, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 185 Literaturangaben.
Abstract (Originalsprache)
Cancer remains the leading cause of death worldwide. The treatment of cancer has become increasing complex. Current treatment options for cancer include surgical resection, chemotherapy, radiotherapy, nanomedicine, and immunotherapy. Recent experimental and clinical studies have provided substantial evidence supporting the potential use of melatonin as a preventive and therapeutic agent in oncology. Melatonin (N-acetyl-5-methoxy-tryptamine), a pleiotropic and multitasking molecule, is secreted from the pineal gland during the night under normal light-dark conditions. Beyond its role in circadian regulation, melatonin exhibits antioxidant, anti-aging, immunomodulatory, and anti-cancer properties. Melatonin exerts significant apoptotic, angiogenic, oncostatic, and anti-proliferative effects on a variety of cancer cells. This review discusses the influence of melatonin on cancer cells through mechanisms involving cell cycle regulation, stimulation of apoptosis, autophagy induction, epigenetic modification, and transcriptional regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Student Research Committee, Urmia University of Medical Sciences, Urmia, 57147-83734, Iran.
- Department of Clinical Biochemistry and Applied Cell Sciences, School of Medicine, Urmia University of Medical Sciences, Urmia, 57147-83734, Iran.
- Department of Clinical Biochemistry, School of Medicine, Babol University of Medical Sciences, Babol, 47176-47754, Iran.
- Student Research Committee, Babol University of Medical Sciences, Babol, 47176-47754, Iran.
- Department of Medicinal Plants, Faculty of Agriculture and Natural Resources, Arak University, Arak, 38156-88349, Iran.
- Metabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Zitieren
APA
Maghsoudi, H., Sheikhnia, F., Hajmalek, N., Gholipour, F. D., Alipour, S., Ghorbanpour, M., Farzanegan, S., Mir, S. M., & Memar, M. Y. (2025). Multifaceted roles of melatonin in oncology: an insight into its therapeutic potential in cancer management. Inflammopharmacology, 33(5), 2477-2492. https://doi.org/10.1007/s10787-025-01751-9
Vancouver
Maghsoudi H, Sheikhnia F, Hajmalek N, Gholipour FD, Alipour S, Ghorbanpour M, et al. Multifaceted roles of melatonin in oncology: an insight into its therapeutic potential in cancer management. Inflammopharmacology. 2025;33(5):2477-2492. doi:10.1007/s10787-025-01751-9
BibTeX
@article{Maghsoudi2025,
author = {Maghsoudi, Hossein and Sheikhnia, Farhad and Hajmalek, Nooshin and Gholipour, Fatemeh Dadash and Alipour, Shahriar and Ghorbanpour, Mansour and Farzanegan, Sara and Mir, Seyed Mostafa and Memar, Mohammad Yousef},
title = {Multifaceted roles of melatonin in oncology: an insight into its therapeutic potential in cancer management},
journal = {Inflammopharmacology},
year = {2025},
volume = {33},
number = {5},
pages = {2477--2492},
doi = {10.1007/s10787-025-01751-9}
}
EUVIMED